🧬 💉 🔬 https://www.news-medical.net/news/20240103/EZH2-inhibitors-s…tment.aspx Type1Diabetes # EZH2Inhibitors # BetaCellRegener…
Study explores the potential of EZH2 inhibitors GSK126 and Tazemetostat in stimulating β-cell regeneration from pancreatic ductal progenitor cells, offering a novel therapeutic approach for Type 1 Diabetes.
Leave a reply